Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06624592
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Delirium on Emergence
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 7 Years
- Healthy Volunteers
- Not accepted
Interventions
- Sevoflurane — DRUGSubjects will receive standard of care anesthesia Sevoflurane, with intravenous push Dexmedetomidine
- Isoflurane — DRUGSubjects will receive standard of care anesthesia Isoflurane
Study Details
The purpose of this study is to measure the incidences of pediatric emergence delirium between the group receiving Isoflurane and the group receiving Sevoflurane plus intravenous push dexmedetomidine.
Key Dates
- Start date
- Dec 20, 2024
- Status verified
- Dec 2025
- Primary completion
- Nov 1, 2026
- Completion
- Nov 1, 2026
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Isoflurane group
- Active Comparator: Sevoflurane group
Primary Outcome Measure
Number of subjects with emergence delirium [ Time Frame: Within 1 hour after dropped off by anesthesiology team ]
Central Contacts
- Lindsay Warner, MD507-284-2511
- Molly Herr, MD507-284-2511
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Lindsay Warner (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By research site